Vitalhub Corp. (TSE:VHI – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is C$13.14.
A number of research analysts have recently weighed in on VHI shares. ATB Cormark Capital Markets dropped their target price on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. Raymond James Financial dropped their target price on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. Finally, National Bank Financial dropped their target price on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a report on Wednesday, May 27th.
Get Our Latest Analysis on VHI
Insider Buying and Selling
Vitalhub Stock Performance
Shares of TSE:VHI opened at C$7.17 on Friday. The business’s 50 day simple moving average is C$7.47 and its two-hundred day simple moving average is C$8.20. The firm has a market cap of C$453.57 million, a P/E ratio of 59.75, a PEG ratio of 1.18 and a beta of 0.88. Vitalhub has a 52-week low of C$6.67 and a 52-week high of C$14.64.
Vitalhub (TSE:VHI – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. The business had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%. On average, equities analysts forecast that Vitalhub will post 0.2296467 earnings per share for the current fiscal year.
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Read More
- Five stocks we like better than Vitalhub
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
